For more than a decade, our research has mapped how RNA methylation governs cellular survival. That work uncovered a critical dependency in cancer cells on the demethylase FTO.

Today, Tinos Tx translates that insight into first-in-class small molecule inhibitors designed to destabilize tumor-driving RNA and collapse cancer from within.